reference/27148131

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27148131

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
issn	0045-2068
pageRange	104595-
publicationName	Bioorganic Chemistry
startingPage	104595
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_274de0cd095daad44a563971b32f4582 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_83d3ea6cd9c5454848830b623dcc18cf
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c60d28e809da60938f73e90b84e34bed http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_48ae11a6b8533c0968309242d1f9eac4 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_96399cf467d751009df55ca07098ae89
bibliographicCitation	Roy T, Boateng ST, Banang-Mbeumi S, Singh PK, Basnet P, Chamcheu RN, Ladu F, Chauvin I, Spiegelman VS, Hill RA, Kousoulas KG, Nagalo BM, Walker AL, Fotie J, Murru S, Sechi M, Chamcheu JC. Synthesis, inverse docking-assisted identification and in vitro biological characterization of Flavonol-based analogs of fisetin as c-Kit, CDK2 and mTOR inhibitors against melanoma and non-melanoma skin cancers. Bioorganic Chemistry. 2021 Feb;107():104595. doi: 10.1016/j.bioorg.2020.104595.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db4c64b07bff7a7a8c86f38e87fe5c30 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4185dbc015f6d2e19f818b1e3836603 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4950f99cdf2a33a2cfce6e2f2234793 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d803751f66ef3f409c58c67cdcbecc4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e059b9f2d36017fee163f544431ac856 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48e670421a67a5afe96abf2a6961f6cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7fa0b2cc985bb5e3e50e928e4af156d7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e881c851d936a48a6e5efa6e82a0981c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c7654cc9d4a815403c068cf0a2b97e2c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f06b27df98de750d60ba46fb96bc71df http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2809-2536 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c35020d94d7d9d60c4bf7ce879ccb0e http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3101-7705 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_90e47b6d42d4169d8e7e2df33ef83bfc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b0abd18227d0b81780bbb80ebb1b149 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07bffed7b038d0be248b479068dbd015 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c521e52d8730e9a005063b7dae9593a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3276d563246a37c5060ef109fd23b438 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e4b54d5ba31f7648ceb2dafab91a6fe
date	202102
identifier	https://pubmed.ncbi.nlm.nih.gov/33450548 https://doi.org/10.1016/j.bioorg.2020.104595 https://pubmed.ncbi.nlm.nih.gov/PMC7870562
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20408 https://portal.issn.org/resource/ISSN/0045-2068
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Synthesis, inverse docking-assisted identification and in vitro biological characterization of Flavonol-based analogs of fisetin as c-Kit, CDK2 and mTOR inhibitors against melanoma and non-melanoma skin cancers
discusses	http://id.nlm.nih.gov/mesh/M0480239 http://id.nlm.nih.gov/mesh/M0068970 http://id.nlm.nih.gov/mesh/M0060378 http://id.nlm.nih.gov/mesh/M0191671 http://id.nlm.nih.gov/mesh/M0028387 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0469193 http://id.nlm.nih.gov/mesh/M000645815 http://id.nlm.nih.gov/mesh/M0543256
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008545Q000188 http://id.nlm.nih.gov/mesh/D000970Q000494 http://id.nlm.nih.gov/mesh/D012878Q000188 http://id.nlm.nih.gov/mesh/D044948Q000494 http://id.nlm.nih.gov/mesh/D062105
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D058570Q000378 http://id.nlm.nih.gov/mesh/D019009Q000378 http://id.nlm.nih.gov/mesh/D019009Q000037 http://id.nlm.nih.gov/mesh/D013329 http://id.nlm.nih.gov/mesh/D044948Q000737 http://id.nlm.nih.gov/mesh/D015394 http://id.nlm.nih.gov/mesh/D014407 http://id.nlm.nih.gov/mesh/D002470Q000187 http://id.nlm.nih.gov/mesh/D058570Q000037 http://id.nlm.nih.gov/mesh/D017209Q000187 http://id.nlm.nih.gov/mesh/D000970Q000138 http://id.nlm.nih.gov/mesh/D044948Q000138 http://id.nlm.nih.gov/mesh/D051357Q000037 http://id.nlm.nih.gov/mesh/D004354 http://id.nlm.nih.gov/mesh/D012878Q000473 http://id.nlm.nih.gov/mesh/D012878Q000378 http://id.nlm.nih.gov/mesh/D051357Q000378 http://id.nlm.nih.gov/mesh/D049109Q000187 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D008545Q000473 http://id.nlm.nih.gov/mesh/D008545Q000378 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000970Q000737
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.22.56 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5f8f19d61252fdce5cae1f415ad035b2 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ffa044f5d18974a3264c23a5e1e06217 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9245 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281614 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_467b750f9a6073f1098d1aa6270e135d http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4f3366af2ce1555e259faab86aad3bef http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f6e823973728aec8c3075d39388b14dd http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11349 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.22.61 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.22.60

Total number of triples: 95.